Le Danny, Hydro Brody A, Jones Chase L, Beauchamp Gillian A
Department of Emergency and Hospital Medicine, Lehigh Valley Health Network/University of South Florida (USF) Morsani College of Medicine, Allentown, USA.
Department of Emergency and Hospital Medicine, Division of Medical Toxicology, Lehigh Valley Health Network/University of South Florida (USF) Morsani College of Medicine, Allentown, USA.
Cureus. 2023 Jul 12;15(7):e41778. doi: 10.7759/cureus.41778. eCollection 2023 Jul.
This case describes a 56-year-old man with a past medical history including sickle cell trait requiring blood transfusions, who presented to the emergency department (ED) with generalized weakness and fatigue following supplementation. Initial laboratory abnormalities included: aspartate aminotransferase (AST) and alanine transaminase (ALT) 4,222 U/L and 4,664 U/L respectively, alkaline phosphatase 215 U/L, international normalized ratio (INR) 3.2, and his model for end-stage liver disease was 37. Creatinine, hemoglobin and hematocrit, and ferritin levels were all elevated. The differential diagnosis for his acute illness was broad ranging from hemochromatosis, anabolic steroid use, and portal venous thrombosis. The patient was started on N-acetylcysteine (NAC) and his liver function improved. He was discharged on hospital day 10 and instructed to discontinue his supplements and follow up for repeat blood work. This case explores the critical management of toxicity. The patient explored as an herbal supplementation resulting in weight loss, worsening generalized fatigue, and fulminant hepatic failure.
本病例描述了一名56岁男性,既往有包括镰状细胞性状(需输血)在内的病史,在补充营养后出现全身无力和疲劳,前往急诊科就诊。初始实验室检查异常包括:天冬氨酸氨基转移酶(AST)和丙氨酸氨基转移酶(ALT)分别为4222 U/L和4664 U/L,碱性磷酸酶215 U/L,国际标准化比值(INR)3.2,终末期肝病模型评分为37。肌酐、血红蛋白、血细胞比容和铁蛋白水平均升高。其急性疾病的鉴别诊断范围广泛,包括血色素沉着症、使用合成代谢类固醇和门静脉血栓形成。患者开始使用N-乙酰半胱氨酸(NAC)治疗,肝功能得到改善。患者于住院第10天出院,并被指示停用补充剂,随后进行复查血检。本病例探讨了毒性的关键管理。患者使用了一种草药补充剂,导致体重减轻、全身疲劳加重和暴发性肝衰竭。